Showing 1 - 16 results of 16 for search 'Radivoyevitch, T', query time: 0.05s
Refine Results
-
1
A two-way interface between limited Systems Biology Markup Language and R by Radivoyevitch Tomas
Published 2004-12-01
Article -
2
-
3
-
4
Modelling c-Abl Signalling in Activated Neutrophils: The Anti-inflammatory Effect of Seliciclib by Robert C. Jackson, Tomas Radivoyevitch
Published 2013-03-01
Article -
5
-
6
On systems and control approaches to therapeutic gain by Jackson Robert C, Loparo Kenneth A, Radivoyevitch Tomas, Sedwick W David
Published 2006-04-01
Article -
7
-
8
dNTP Supply Gene Expression Patterns after P53 Loss by Mark Jackson, Charles A. Kunos, Gina Ferris, Damian Junk, Ian Lent, Yogen Saunthararajah, Tomas Radivoyevitch, John Pink
Published 2012-11-01
Article -
9
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study by Kunos Charles, Radivoyevitch Tomas, Abdul-Karim Fadi W, Fanning James, Abulafia Ovadia, Bonebrake Albert J, Usha Lydia
Published 2012-04-01
Article -
10
PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation by Xiaorong Gu, Francis Enane, Rita Tohme, Caroline Schuerger, Tomas Radivoyevitch, Yvonne Parker, Eric Zuberi, Bartlomiej Przychodzen, Babal Kant Jha, Daniel Lindner, Brian Rini, Yogen Saunthararajah
Published 2021-09-01
Article -
11
Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation by Kang Wang, Zhuyue Li, Xingxing Chen, Jianjun Zhang, Yongfu Xiong, Guochao Zhong, Yang Shi, Qing Li, Xiang Zhang, Hongyuan Li, Tingxiu Xiang, Theodoros Foukakis, Tomas Radivoyevitch, Guosheng Ren
Published 2021-03-01
Article -
12
Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy by Sudipta Biswas, Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt Schalper, Hua Zhang, Daniel J. Lindner, Anish Thomas, David MacPherson, Brian Gastman, David S. Schrump, Kwok-Kin Wong, Vamsidhar Velcheti, Yogen Saunthararajah
Published 2023-08-01
Article -
13
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q by Adema, V, Palomo, L, Walter, W, Mallo, M, Hutter, S, La Framboise, T, Arenillas, L, Meggendorfer, M, Radivoyevitch, T, Xicoy, B, Pellagatti, A, Haferlach, C, Boultwood, J, Kern, W, Visconte, V, Sekeres, M, Barnard, J, Haferlach, T, Solé, F, Maciejewski, JP
Published 2022Journal article -
14
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q by Vera Adema, Laura Palomo, Wencke Walter, Mar Mallo, Stephan Hutter, Thomas La Framboise, Leonor Arenillas, Manja Meggendorfer, Tomas Radivoyevitch, Blanca Xicoy, Andrea Pellagatti, Claudia Haferlach, Jacqueline Boultwood, Wolfgang Kern, Valeria Visconte, Mikkael Sekeres, John Barnard, Torsten Haferlach, Francesc Solé, Jaroslaw P. Maciejewski
Published 2022-06-01
Article -
15
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. by Robert Molokie, Donald Lavelle, Michel Gowhari, Michael Pacini, Lani Krauz, Johara Hassan, Vinzon Ibanez, Maria A Ruiz, Kwok Peng Ng, Philip Woost, Tomas Radivoyevitch, Daisy Pacelli, Sherry Fada, Matthew Rump, Matthew Hsieh, John F Tisdale, James Jacobberger, Mitch Phelps, James Douglas Engel, Santhosh Saraf, Lewis L Hsu, Victor Gordeuk, Joseph DeSimone, Yogen Saunthararajah
Published 2017-09-01
Article -
16
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells by Feng Pan, Thomas S. Wingo, Zhigang Zhao, Rui Gao, Hideki Makishima, Guangbo Qu, Li Lin, Miao Yu, Janice R. Ortega, Jiapeng Wang, Aziz Nazha, Li Chen, Bing Yao, Can Liu, Shi Chen, Ophelia Weeks, Hongyu Ni, Brittany Lynn Phillips, Suming Huang, Jianlong Wang, Chuan He, Guo-Min Li, Tomas Radivoyevitch, Iannis Aifantis, Jaroslaw P. Maciejewski, Feng-Chun Yang, Peng Jin, Mingjiang Xu
Published 2017-04-01
Article